Provensis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROVENSIS, and when can generic versions of PROVENSIS drugs launch?
PROVENSIS has one approved drug.
There are four US patents protecting PROVENSIS drugs.
There are eighty-two patent family members on PROVENSIS drugs in thirty countries.
Summary for Provensis
| International Patents: | 82 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Provensis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 7,731,986 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 7,814,943 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 8,122,917 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-002 | Dec 21, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 9,480,652 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Provensis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | 8,323,677 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | 7,357,336 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | 6,572,873 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | 8,734,833 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RE40640 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RE38919 | ⤷ Try a Trial |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | 7,025,290 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Provensis Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2006121443 | ⤷ Try a Trial |
| United Kingdom | 0321210 | ⤷ Try a Trial |
| Spain | 2330341 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2007045897 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2005023678 | ⤷ Try a Trial |
| India | 7569DEN2014 | ⤷ Try a Trial |
| Canada | 2546227 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
